Richard Kender

Richard Kender most recently served as Senior Vice President of Business Development and Corporate Licensing at Merck. Mr. Kender spent his entire professional career at the company in various corporate roles of increasing responsibility. At Merck, Mr. Kender was involved in more than 100 business development and licensing transactions. Currently, he also serves on the Board of Directors of Poxel, Bicycle Therapeutics PLC and ReViral Ltd. He has previously served on the Boards of Directors of INC Research Holdings, Inc., Abide Therapeutics and FoxHollow Technologies Inc. Mr. Kender earned his B.S. in accounting from Villanova University and his MBA from Fairleigh Dickinson University.